Annual Shareholders Equity
$12.77 M
-$1.92 M-13.08%
December 1, 2023
Summary
- As of February 7, 2025, TNFA annual stockholders equity is $12.77 million, with the most recent change of -$1.92 million (-13.08%) on December 1, 2023.
- During the last 3 years, TNFA annual shareholders equity has risen by +$18.03 million (+342.98%).
- TNFA annual shareholders equity is now -45.98% below its all-time high of $23.65 million, reached on December 1, 2021.
Performance
TNFA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$17.05 M
+$16.67 M+4361.16%
September 1, 2024
Summary
- As of February 7, 2025, TNFA quarterly stockholders equity is $17.05 million, with the most recent change of +$16.67 million (+4361.16%) on September 1, 2024.
- Over the past year, TNFA quarterly shareholders equity has increased by +$4.28 million (+33.52%).
- TNFA quarterly shareholders equity is now -48.97% below its all-time high of $33.42 million, reached on March 1, 2021.
Performance
TNFA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
TNFA Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.1% | +33.5% |
| 3 y3 years | +343.0% | -6.9% |
| 5 y5 years | +343.0% | -49.0% |
TNFA Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -46.0% | at low | -27.9% | +4361.2% |
| 5 y | 5-year | -46.0% | +343.0% | -49.0% | +424.4% |
| alltime | all time | -46.0% | +343.0% | -49.0% | +424.4% |
TNF Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $17.05 M(+4361.2%) |
| Jun 2024 | - | $382.30 K(-96.3%) |
| Mar 2024 | - | $10.24 M(-19.8%) |
| Dec 2023 | $12.77 M(-13.1%) | $12.77 M(-20.7%) |
| Sep 2023 | - | $16.11 M(+50.0%) |
| Jun 2023 | - | $10.74 M(-23.3%) |
| Mar 2023 | - | $14.01 M(-4.7%) |
| Dec 2022 | $14.70 M | $14.70 M(-19.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $18.33 M(+13.7%) |
| Jun 2022 | - | $16.12 M(-17.9%) |
| Mar 2022 | - | $19.62 M(-17.0%) |
| Dec 2021 | $23.65 M(-549.8%) | $23.65 M(-8.7%) |
| Sep 2021 | - | $25.89 M(-16.7%) |
| Jun 2021 | - | $31.07 M(-7.0%) |
| Mar 2021 | - | $33.42 M(-735.8%) |
| Dec 2020 | -$5.26 M | -$5.26 M |
FAQ
- What is TNF Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for TNF Pharmaceuticals?
- What is TNF Pharmaceuticals annual shareholders equity year-on-year change?
- What is TNF Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for TNF Pharmaceuticals?
- What is TNF Pharmaceuticals quarterly shareholders equity year-on-year change?
What is TNF Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of TNFA is $12.77 M
What is the all time high annual shareholders equity for TNF Pharmaceuticals?
TNF Pharmaceuticals all-time high annual stockholders equity is $23.65 M
What is TNF Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, TNFA annual stockholders equity has changed by -$1.92 M (-13.08%)
What is TNF Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of TNFA is $17.05 M
What is the all time high quarterly shareholders equity for TNF Pharmaceuticals?
TNF Pharmaceuticals all-time high quarterly stockholders equity is $33.42 M
What is TNF Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, TNFA quarterly stockholders equity has changed by +$4.28 M (+33.52%)